Delivery Order SPE2DB20D1110-SPE2DB25FK39J
- Not listed
- The Defense Logistics Agency awarded a $8,587.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a single delivery order for continuous glucose monitoring sensors to support federal medical supply needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $4,852.65 on August 27, 2025, with completion expected by August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.19 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The sensors will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $18,029.34 delivery order to AmerisourceBergen Drug Corp for FreeStyle Libre 3 Plus sensors, a continuous glucose monitoring system used for diabetes management. This firm fixed-price contract, awarded on September 3, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,655.70 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a $1,119.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitive award, with no set-aside designation, is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader federal contract portfolio with the DLA....
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.79 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This competitively awarded, firm fixed price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive partnership with DLA to supply critical medical devices and pharmaceuticals to support military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.04 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device...
- The Defense Logistics Agency awarded a delivery order valued at $3,461.82 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK39JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,578.56 in Freestyle Libre 3 Plus continuous glucose monitoring sensors, with completion scheduled for September 10, 2025. This firm fixed-price delivery order, awarded on September 9, 2025, represents a non-competitive award under a larger indefinite delivery contract vehicle. The sensors will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order is issued under AmerisourceBergen's primary Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a critical pharmaceutical and medical supply distributor for federal healthcare systems, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medical commodities to military and veteran healthcare programs. The Freestyle Libre sensors support diabetes management capabilities across the Defense Health Agency and other federal healthcare beneficiaries, consistent with the company's extensive portfolio of specialty medications and medical devices delivered through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/9/25 |